SAMSARA BIOCAPITAL, LLC – Terns Pharmaceuticals, Inc. Transaction History
SAMSARA BIOCAPITAL, LLC portfolio value:
$1.70M
portfolio value
SAMSARA BIOCAPITAL, LLC quarter portfolio value change:
+137.50%
quarter
Terns Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 986K | $5.89 | 289.06K | |
| Q2 2022 | share | 0.00% | 0 shares | -142K | $2.48 | 289.06K | |
| Q1 2022 | share | 0.00% | 0 shares | -1.18M | $2.97 | 289.06K | |
| Q4 2021 | share | 0.00% | 0 shares | -968K | $6.21 | 289.06K | |
| Q3 2021 | share | 0.00% | 0 shares | -532K | $10.42 | 289.06K | |
| Q2 2021 | share | Decrease | -41.90% | -208.48K shares | -7.40M | $12.26 | 289.06K |
| Q1 2021 | share | Increase | 0.00% | 497.55K shares | 10.94M | $22 | 497.55K |